Synthesis and in vitro evaluation of naphthalimide–benzimidazole conjugates as potential antitumor agents?

Organic & Biomolecular Chemistry Pub Date: 2019-05-01 DOI: 10.1039/C8OB02973C

Abstract

A series of novel naphthalimide–benzimidazoles was designed and synthesized for the first time and studied for their effect on antiproliferative activity. Some of these compounds possessed good antitumor activity towards the tested cancer cell lines. Noticeably, (diethylamino)ethyl 15 and (dimethylamino)ethyl 23 derivatives displayed superior antiproliferative activity towards human cancer cell lines with MG_MID GI50 values of 1.43 and 1.83 μM, respectively. Preliminary investigation revealed that compounds 15 and 23 might bind with ct-DNA through the intercalation mode which is responsible for potent bioactivity. Moreover, transportation behaviour indicated that these molecules could efficiently bind to and be carried by bovine albumin, and the hydrogen bonding and hydrophobic interactions played important roles in interaction with serum albumin.

Graphical abstract: Synthesis and in vitro evaluation of naphthalimide–benzimidazole conjugates as potential antitumor agents
Recommended Literature